Mark de Souza

Mark de Souza is a seasoned executive with extensive experience in the biotechnology and pharmaceuticals sectors. Currently serving as President and CEO at SonALAsense since January 2019, Mark has also held prominent positions such as Co-Founder and President at Willow Neuroscience and Co-Founder and Executive Chairman at Flightpath Biosciences, Inc. Mark's expertise extends to significant roles in various startups, including Co-Founder and Board Member at Phoenicis Therapeutics and NFlection Therapeutics, as well as leadership positions at Chromaderm Inc, FIBRX Derm, Inc., and SeylanMED, LLC. Additionally, Mark contributed as Executive Chairman at PellePharm and served as a consultant for Shire.